CTRI/2021/11/037842Not yet recruiting未知
Dosimetric Comparison of Stereotactic Radiotherapy (SRT) Treatment plan with and without the use of Micro Multileaf Collimator (mMLC)
RECHAL NISHA DSOUZA0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •CT scans of patients undergoing SRT treatment.
Exclusion Criteria
- •Patients unfit for Radiation therapy and being considered for hypofractionated brachytherapy procedures
Investigators
Similar Trials
Completed
Unknown
Comparison between stereotactic body radiotherapy and transcatheter arterial chemoembolization for hepatocellular carcinoma: Meta-analysis and systematic review.Hepatocellular carcinomaJPRN-UMIN000051712Yokohama City University Medical Center
Recruiting
Phase 1
Phase I/II study of stereotactic radiotherapy for renal cell cancerJPRN-UMIN000004172niversity of Yamanashi30
Completed
Phase 2
Phase II study of stereotactic radiotherapy with volumetric modulated arc therapy for primary lung cancer located adjacent to organ at riskJPRN-UMIN000022856Department of Radiuation Oncology, Tohoku University Graduate School of Medicine15
Active, not recruiting
Phase 2
Stereotactic Radiotherapy for Oligoprogressive ER-positive Breast Cancer. AVATAR.ER-positive, HER2-negative advanced breast cancerCancer - BreastBreast CancerAdvanced breast cancerACTRN12620001212943Peter Mac Callum Cancer Centre32
Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerprostate cancerJPRN-jRCT1030220062Yamashita Hideomi36